Skip to main content
Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
74.96
+2.32 (3.19%)
At close: Jun 26, 2026, 4:00 PM EDT
74.90
-0.06 (-0.08%)
After-hours: Jun 26, 2026, 7:45 PM EDT

Halozyme Therapeutics Employees

Halozyme Therapeutics had 423 employees as of December 31, 2025. The number of employees increased by 73 or 20.86% compared to the previous year.

Employees
423
Change (1Y)
73
Growth (1Y)
20.86%
Revenue / Employee
$3,566,095
Profits / Employee
$824,688
Market Cap
8.89B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20254237320.86%
Dec 31, 2024350-23-6.17%
Dec 31, 2023373-20-5.09%
Dec 31, 2022393248171.03%
Dec 31, 202114596.62%
Dec 31, 202013643.03%
Dec 31, 2019132-149-53.02%
Dec 31, 20182812610.20%
Dec 31, 2017255-4-1.54%
Dec 31, 20162594319.91%
Dec 31, 20152166341.18%
Dec 31, 2014153-17-10.00%
Dec 31, 20131701811.84%
Dec 31, 20121521712.59%
Dec 31, 20111353332.35%
Dec 31, 2010102-38-27.14%
Dec 31, 2009140107.69%
Dec 31, 20081303841.30%
Dec 31, 20079252130.00%
Dec 31, 200640--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.

Related Stocks

Company Name Employees
Bio-Techne 3,100
Corcept Therapeutics 730
ImmunityBio 691
Vaxcyte 507
TG Therapeutics 399
Immunovant 315
Kymera Therapeutics 253
Praxis Precision Medicines 168
Employee Rankings

HALO News

More News